PAX-101 meaningfully improves core symptoms of autism
In a phase II trial, PAX-101 (IV suramin) significantly improved…
In a phase II trial, PAX-101 (IV suramin) significantly improved symptoms in children with moderate to severe autism spectrum disorder (ASD).